Product Categories
Country: | China |
---|---|
Tel: | 0513-66337626 |
Mobile: | 18051384581 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
ODN 1826 | 202668-42-6 | Details |
Topoisomerase I inhibitor 8 | C24H21FN2O4 | 210346-40-0 | Details |
2-(N-(2,6-Difluoropyridin-4-yl)cyanamido)-5-methyl-N-(spiro[3.4]octan-1-yl)thiazole-4-carboxamide | C19H19F2N5OS | 2431970-42-0 | Details |
ERD-12310A | Details |
Gliocidin | Details |
Ziresovir | C22H25N5O3S | 1422500-60-4 | Details |
Difluoromethylornithine | C6H12F2N2O2 | 70052-12-9 | Details |
3-Deazaneplanocin | C12H14N4O3 | 102052-95-9 | Details |
CB-6644 | C29H34ClFN4O5 | 2316817-88-4 | Details |
Capzimin | C30H24N6O2S4 | 2084868-04-0 | Details |
JNJ-28583113 | C19H21F3N2O2 | 2765255-93-2 | Details |
OGT2115 | C24H16BrFN2O4 | 853929-59-6 | Details |
Pentamidine | C19H24N4O2 | 100-33-4 | Details |
Lupichromone | C19H22O4 | 162616-72-0 | Details |
1α-Hydroxy-3-epi-vitamin D3 | C27H44O2 | 58028-00-5 | Details |
SIRT5 inhibitor 7 | 2951090-00-7 | Details |
IWY357/NVP-IWY357 | C18H20F5N5OS | 3052672-51-9 | Details |
BMS-986397 | C21H16ClF3N4O4 | 2564486-44-6 | Details |
TYRA-300 | C25H24Cl2N6O3S | 2800223-30-5 | Details |
GS-1156(Elunonavir) | C52H59F10N11O8 | 2242428-57-3 | Details |
NVP-DFF332 | Details |
CHF-6523 | C33H32N8O3 | 2500579-21-3 | Details |
BAY-2413555 | 2206665-50-9 | Details |
NVP-EVS459 | Details |
BAY2925976 | C21H27F2N5OS | 2642235-06-9 | Details |
WSF1-IN-1 | C20 H21 F3 N8 O | 2379577-82-7 | Details |
2228847-12-7 | 2228847-12-7 | Details |
SMAP-2 | C27H27F3N2O4S | 1809068-70-9 | Details |
VX-166 | C22H21F4N3O8 | 800408-39-3 | Details |
RXP03 | 284667-65-8 | Details |
MS8790 | 3060730-06-2 | Details |
AN-3485 | C14H13BClNO3 | 1213827-99-6 | Details |
XIAP antagonist 1 | C23H25ClN4O3 | 375835-04-4 | Details |
Iopromide Impurity 31 | C11H12I3N3O4 | 872117-56-1 | Details |
Apicularen A | C25H31NO6 | 220757-04-0 | Details |
STING agonist-32 | 2591300-74-0 | Details |
BGT1-IN-9 | C5H10ClN3O2 | 185444-92-2 | Details |
(S)-IDO1-IN-5 | C23H25FN2O3 | 2166616-76-6 | Details |
DKFZ-251 | C24H24N4O3 | 2222059-70-1 | Details |
Rocaglaol | C26H26O6 | 147059-46-9 | Details |
Lepadin H | 412328-25-7 | Details |
N-(3-Oxoundecanoyl)-L-homoserine lactone | C15H25NO4 | 216596-70-2 | Details |
TDP-43-IN-2 | C22H22FN5O2S | 3033951-93-5 | Details |
BMD4503-2 | C26H21N5O3S | 301357-87-9 | Details |
Asulacrine free base | C24H24N4O4S | 80841-47-0 | Details |
Ulevostinag/MK-1454 | C20H22F2N10O9P2S2 | 2231258-61-8 | Details |
2641821-68-1 | 2641821-68-1 | Details |
2764998-32-3 | C29H36IN5O5S | 2764998-32-3 | Details |
2764998-33-4 | C35H48BN5O7S | 2764998-33-4 | Details |
P62-mediated mitophagy inducer | C14H9IN4O2 | 1809031-84-2 | Details |
N-[(4S)-1-Acetyl-1,2,3,4-tetrahydro-4-methyl-4-phenyl-6-quinolinyl]-3-(trifluoromethyl)benzenepropanamide | C28H27F3N2O2 | 1421683-12-6 | Details |
LU-002i | 1838705-22-8 | Details |
Proteasome β2c/i-IN-1 | 2322333-75-3 | Details |
STAT3 inhibitor C188 | C19H15NO7S2 | 823828-18-8 | Details |
Mrgx2 antagonist-2 | C23H21F4N5O3 | 2767111-67-9 | Details |
3932-44-3 | 3932-44-3 | Details |
Biotinyl-NH-PEG3-C3-amido-C3-COOH | C25H44N4O8S | 1202761-21-4 | Details |
VRK-IN-1 | C18H11F4NO2 | 2378855-09-3 | Details |
(E)-3-Methyl-5-(phosphonooxy)pent-2-enoic acid | 2271369-82-3 | Details |
RTC13 | C14H9N3O4S | 1359825-94-7 | Details |
Luffariellolide | C25H38O3 | 111149-87-2 | Details |
Cbl-b-IN-27 | Details |
BLI-489 | C13H12N3NaO5S | 623564-40-9 | Details |
CP-346086 dihydrate | C26H22F3N5O | 186390-48-7 | Details |
STING agonist-16 | C19H11Cl2N5O | 652142-94-4 | Details |
MLS0315771 | C15H12FNOS | 727664-91-7 | Details |
AZD7687 | C21H25N3O3 | 1166827-44-6 | Details |
MC-Val-Cit-PAB-clindamycin | C46H72ClN8O11S+ | 1639793-13-7 | Details |
eIF4A3-IN-9 | C28H27NO8 | 1402931-71-8 | Details |
DMP 777 | C31H40N4O6 | 157341-41-8 | Details |
IDX184 | C25H35N6O9PS | 1036915-08-8 | Details |
Cot inhibitor 1 | C27H27Cl2FN8 | 915365-57-0 | Details |
BIIB-129 | 2770960-52-4 | Details |
STING antagonist 1 | 3036981-21-9 | Details |
L-Moses/L-45 | C21H24N6 | 2079885-05-3 | Details |
Pirarubicin HCl | C32H38ClNO12 | 95343-20-7 | Details |
2,2-Dimethyl-thiomorpholin-3-one | C6H11NOS | 50847-92-2 | Details |
Glycine, N-[N-[N-[N-[N-[N-[(1,1-dimethylethoxy)carbonyl]glycyl]glycyl]glycyl]glycyl]glycyl]- (9CI) | C17H28N6O9 | 155521-05-4 | Details |
2-(4-(1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethyl 4-methylbenzenesulfonate | 2889433-07-0 | Details |
VX993 | 2877755-11-6 | Details |
2-Chloro-6-methoxy-3-quinolinecarboxaldehyde | C11H8ClNO2 | 73568-29-3 | Details |
N-Cyclopentyl-2-((1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(3-phenylureido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl)acetamide | 2986044-04-4 | Details |
Indomethacin formaldehyde (impurity) | C18H14ClNO3 | 23694-51-1 | Details |
ZK53 | C19H20BrF2N3O | 3031789-26-8 | Details |
RJW100 | C28H34O | 1276664-20-0 | Details |
LRH-1 modulator-1 | C28H36N2O2S | 2244781-29-9 | Details |
PC7A | Details |
Product Total: Product Page: | ||||
30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 |